BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

NEXUS Biosystems, Inc. Announces Acquisition of Aurora Biotechnologies


12/7/2009 7:18:42 AM

Bookmark and Share

POWAY, Calif.--(BUSINESS WIRE)--NEXUS Biosystems, Inc. (“Nexus”), a leading innovator and worldwide provider of automated sample management systems, today announced the acquisition of Aurora Biotechnologies of Carlsbad, CA (“Aurora”), a leading developer of proprietary high performance microplates for use in sample storage, high-throughput screening, and cellular imaging.

“Combining the technologies and personnel of Aurora with Nexus will enable us to provide a wider spectrum of products for our current and future customers around the world,” said John Lillig, President and Chief Executive Officer of Nexus. “With the recent launch of our automated -80°C BioStore line of sample management systems and our new XPeel microplate de-sealer, 2009 has been a strong growth year for Nexus. As we head into 2010 with the Aurora technologies, we are very excited about the opportunity to expand our product reach beyond automated sample management into high throughput biochemical, cell-based and genomic screening applications.”

Aurora serves the discovery research markets with unique, optically pure consumable microplate products which enable high-throughput analysis of chemical compounds and cellular assays. Aurora provides a broad range of high performance microplate designs, including 96-well, 384-well, 1,536-well and 3,456-well plates. These products are used daily in thousands of experiments in both private and public research institutions around the world. Peter Coassin, President and Chief Technical Officer of Aurora added “Aurora’s legacy in understanding key processes in assay technologies and consumables is a great fit with the Nexus sample management and sample processing technologies. The combination of the two companies is timely as the research market is looking for cost-saving, high quality, efficiency-enhancing solutions.”

About NEXUS Biosystems, Inc.

Nexus is a leading innovator and worldwide provider of enabling technologies and automated sample management systems for pharmaceutical, biotech, agrichemical and research institutions worldwide. Nexus products include the family of Universal Compound Store and Universal BioStore automated sample management systems, the XPeel microplate de-sealer, and the Crystal Farm line of protein crystallization systems. Nexus was founded in 2005, is headquartered in Poway, CA, has a European subsidiary ‘NEXUS Biosystems GmbH’ in Munich, Germany, and has distribution offices throughout the US, Europe and Asia.

For further information about NEXUS Biosystems, please visit www.nexusbio.com.

About Aurora Biotechnologies, Inc.

Aurora Biotechnologies is focused on the development and commercialization of unique, high-performance microplate products, including its proprietary ChemLibTM and MaKOTM high-density plates.

For further information about Aurora, please visit www.aurorabiotechnologies.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6113732<=en

MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6113732 Contact:

NEXUS Biosystems, Inc John Lillig President and Chief Executive Officer 858-679-0770 jlillig@nexusbio.com or Aurora Biotechnologies, Inc. Charles Powell Chief Commercial Officer 866-975-2837 cpowell@aurorabiotechnologies.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES